Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR6 | P50406 | 1/20 | 0.58 |
| ▸ | CA1 | P00915 | 3/20 | 0.52 |
| ▸ | CA2 | P00918 | 3/20 | 0.52 |
| ▸ | TSHR | P16473 | 2/20 | 0.52 |
| ▸ | CA12 | O43570 | 2/20 | 0.52 |
| ▸ | CA7 | P43166 | 2/20 | 0.52 |
| ▸ | CA13 | Q8N1Q1 | 2/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.52 |
| ▸ | CA3 | P07451 | 1/20 | 0.52 |
| ▸ | CA4 | P22748 | 1/20 | 0.52 |
| ▸ | CA6 | P23280 | 1/20 | 0.52 |
| ▸ | CA5A | P35218 | 1/20 | 0.52 |
| ▸ | PLA2G7 | Q13093 | 1/20 | 0.52 |
| ▸ | CA9 | Q16790 | 1/20 | 0.52 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.52 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.52 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19110981 | 1.00 | HTR6 (0.58) | HTR6CA1CA2TSHRCA12 | |
| Hydrochloric Acid SCHEMBL30184245 | 0.97 | HTR6 (0.55) | HTR6CA1CA2TSHRCA12 | |
| Hydrochloric Acid SCHEMBL930597 | 0.97 | HTR6 (0.55) | HTR6CA1CA2TSHRCA12 | |
| Bicarbonate SCHEMBL29219000 | 0.92 | TSHR (0.52) | HTR6CA1CA2TSHRCA12 | |
| SCHEMBL7901727 | 0.92 | TDP1 (0.59) | HTR6CA1CA2TSHRCA12 | |
| Phosphoric Acid SCHEMBL28712122 | 0.87 | ALDH1A1 (0.48) | HTR6CA1CA2TSHRCA12 | |
| Ethylamine SCHEMBL1436591 | 0.85 | PSIP1 (0.54) | HTR6CA1CA2TSHRCA12 | |
| SCHEMBL29128963 | 0.84 | CA12 (0.60) | CA1CA2TSHRCA12ALDH1A1 | |
| Trifluoroacetic Acid SCHEMBL30560569 | 0.83 | CES1 (0.45) | HTR6CA1CA2TSHRCA12 | |
| SCHEMBL11574176 | 0.83 | TSHR (0.56) | HTR6CA1CA2TSHRCA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1184 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4713340-A2 | COMPOSITIONS AND METHODS FOR PEPTIDE-BASED MODULATORS OF HUMAN PAPILLOMAVIRUS ONCOPROTEIN E6 | Calico Life Sciences LLC (US) | 2026-03-25 | — | — | EP | claimed |
| US-12577267-B2 | Pyrimidine compounds for use as MAP4K1 inhibitors | GLENMARK SPECIALITY S.A. (CH) | 2026-03-17 | — | — | US | claimed |
| WO-2025245089-A1 | PROCESSES FOR PREPARING TETRALIN COMPOUNDS | ARCUS BIOSCIENCES, INC. (US) | 2025-11-27 | — | — | WO | claimed |
| EP-4618220-A1 | ELECTROLYTIC SOLUTION FOR NON-AQUEOUS SODIUM ION BATTERIES, NON-AQUEOUS SODIUM ION BATTERY, AND METHOD FOR PRODUCING NON-AQUEOUS SODIUM ION BATTERY | Central Glass Company, Limited (JP) | 2025-09-17 | — | — | EP | claimed |
| CN-120153510-A | Electrolyte for nonaqueous sodium ion battery, and method for producing nonaqueous sodium ion battery | 中央硝子株式会社 | 2025-06-13 | — | — | CN | claimed |
| US-20250188046-A1 | ULTRAFAST FLOW SYNTHESIS OF FUNCTIONALIZED SULFONYL FLUORIDES AND SUBSEQUENT SUFEX CONNECTIONS VIA LITHIATED CHEMISTRY | POSTECH Research and Business Development Foundation (KR) | 2025-06-12 | — | — | US | claimed |
| US-12320012-B2 | Thermal atomic layer etching processes | ASM IP HOLDING B.V. (NL) | 2025-06-03 | — | — | US | claimed |
| WO-2025095666-A1 | NOVEL OXOCYANINE-BASED COMPOUND, PREPARATION METHOD THEREFOR, AND USE THEREOF | 포항공과대학교 산학협력단 | 2025-05-08 | — | — | WO | claimed |
| US-20250146912-A1 | FIXATIVE SOLUTIONS AND METHODS FOR USING SAME | STICHTING RADBOUD UNIVERSITEIT (NL) | 2025-05-08 | — | — | US | claimed |
| CN-116387460-B | Negative electrode plate and preparation method and application thereof | 蜂巢能源科技股份有限公司 | 2025-04-01 | — | — | CN | claimed |
| EP-0910564-A4 | — | — | 1999-04-28 | — | — | EP | claimed |
| EP-0910564-A1 | D-AMINO ACID DERIVED INHIBITORS OF CYSTEINE AND SERINE PROTEASES | CEPHALON, INC. (US) | 1999-04-28 | — | — | EP | claimed |
| EP-0862567-A1 | 5-AZABICYCLO(3.1.0)HEXYLALKYL-2-PIPERIDONES AND -GLUTARIMIDES AS NEUROKININ RECEPTOR ANTAGONISTS | Pfizer Limited (GB) | 1998-09-09 | — | — | EP | claimed |
| US-5798392-A | IRREVERSIBLE ACETYLCHOLINESTERASE INHIBITORS | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 1998-08-25 | — | — | US | claimed |
| WO-1998008497-A1 | SULFONYL FLUORIDES FOR THE TREATMENT OF ALZHEIMER'S DISEASE | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 1998-03-05 | — | — | WO | claimed |
| WO-1997021690-A1 | D-AMINO ACID DERIVED INHIBITORS OF CYSTEINE AND SERINE PROTEASES | CEPHALON, INC. (US) | 1997-06-19 | — | — | WO | claimed |
| WO-1997019942-A1 | 5-AZABICYCLO(3.1.0)HEXYLALKYL-2-PIPERIDONES AND -GLUTARIMIDES AS NEUROKININ RECEPTOR ANTAGONISTS | PFIZER LIMITED (GB) | 1997-06-05 | — | — | WO | claimed |
| US-4886629-A | Process for the preparation of fluorinated benzene sulfonyl fluorides | ALLIED-SIGNAL INC. (US) | 1989-12-12 | — | — | US | claimed |
| US-4117145-A | DIURETIC, HYPOTENSIVE, ANTITHROMBOTIC AGENTS | BAYER AKTIENGESELLSCHAFT (DE) | 1978-09-26 | — | — | US | claimed |
| US-4117143-A | USED AS ANTITHROMBOTIC AGENTS | BAYER AKTIENGESELLSCHAFT (DE) | 1978-09-26 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250188046-A1 | ULTRAFAST FLOW SYNTHESIS OF FUNCTIONALIZED SULFONYL FLUORIDES AND SUBSEQUENT SUFEX CONNECTIONS VIA LITHIATED CHEMISTRY | FGFR4, STS, FGFR1 | HTR6 3280/4885CA1 1003/4885CA2 723/4885 |
| US-12577267-B2 | Pyrimidine compounds for use as MAP4K1 inhibitors | PTK2B, MAP3K10, MAP3K20 | HTR6 3253/4885CA1 4878/4885CA2 3761/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.